Prevention: HPV Vaccine Shows Reduced Recurrence

04/04/2012 12:48 pm ET

A new study suggests that the vaccine against human papillomavirus can significantly cut the likelihood of virus-related disease even among women who have had surgery for cervical cancer caused by HPV.

Using data from a large randomized efficacy trial of the HPV vaccine, the researchers selected a group of 1,350 women 15 to 26 years old who had undergone cervical surgery. Some 587 previously had received the HPV vaccine and 763 a placebo shot.

Read more on The New York Times

Suggest a correction